|
|
Northwest Biotherapeutics, Inc (Inactive Symbol) |
YTD Price Probability |
No random walk data for 2024
|
Default Prediction for 2016-12-31 |
Default prediction by Z-Score (what's this?).
View the other companies in the same industry : N/A
Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):
For manufacuring companies:
Sector Industry |
For non-manufacturing companies:
Sector Industry
|
|
Fundamental Analysis for 2017 |
Fundamental Analysis metrics & ratios (what's this?).
Date of financial statements used: 2017-03-31 |
Book Value: |
$-36.6M |
|
Internal Value: |
$-36.6M |
|
Working Capital: |
$-78.8M |
Debt to Asset Ratio: |
1.758 |
|
Current Ratio: |
0.038 |
|
Turnover Ratio: |
N/A |
Net Margin: |
-18028.6% |
|
EPS: |
-0.266 |
|
P/E ratio: |
-0.601 |
P/B ratio: |
-0.828 |
|
ROE: |
137.8% |
|
ROA: |
-104.5% |
|
|
Company ProfileSymbol: NWBO Market Cap: $30.3M Exchange: NASDAQ Sector: N/A Industry: N/A Data Since: 2002-01-02 Website: www.nwbio.com [Web Query] [News Query]
|